Cargando…
Preventing COVID-19 in low- and middle-income countries
Autores principales: | Khadka, Sitaram, Hashmi, Furqan K., Usman, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152742/ https://www.ncbi.nlm.nih.gov/pubmed/32292266 http://dx.doi.org/10.1007/s40267-020-00728-8 |
Ejemplares similares
-
Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries
por: Adhikari, Sugat, et al.
Publicado: (2020) -
Pharmacometrics: A New Era of Pharmacotherapy and Drug Development in Low- and Middle-Income Countries
por: Usman, Muhammad, et al.
Publicado: (2023) -
Current pharmacy practices in low- and middle-income countries; recommendations in response to the COVID-19 pandemic
por: Hamid, Husnain, et al.
Publicado: (2020) -
The need for COVID-19 research in low- and middle-income countries
por: Gupta, Madhu, et al.
Publicado: (2020) -
COVID-19 vaccines pricing policy options for low-income and middle- income countries
por: Guzman, Javier, et al.
Publicado: (2021)